U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618247) titled 'Single Ascending Doses (SAD) and Multiple Ascending Doses(MAD) Study of IG001119 in Healthy Adult Participants' on May 19.
Brief Summary: The purpose of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IG001119 in Healthy Participants
Study Start Date: June 04
Study Type: INTERVENTIONAL
Condition:
Pain
Intervention:
DRUG: Placebo
Tablets for oral administration.
DRUG: IG001119
Tablets for oral administration.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Iongen Therapeutics Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....